4//SEC Filing
Johnston Robert F 4
Accession 0001422645-09-000004
CIK 0000713275other
Filed
May 11, 8:00 PM ET
Accepted
May 12, 4:52 PM ET
Size
8.3 KB
Accession
0001422645-09-000004
Insider Transaction Report
Form 4
PHARMOS CORPPARS.PK
Johnston Robert F
DirectorExecutive Chairman10% Owner
Transactions
- Award
common stock
2009-05-11$0.22/sh+1,200,000$264,000→ 12,057,949 total(indirect: see footnote) - Other
common stock
2009-05-08$0.05/sh+99,660$5,382→ 10,857,949 total(indirect: see footnote)
Footnotes (4)
- [F1]The Audit Committee of the Pharmos Corporation Board of Directors determined on May 8, 2009 that the shares were earned as a result of the achievement of a clinical milestone under the terms of the operative documents pursuant to which Pharmos Corporation acquired Vela Pharmaceuticals Inc. in October 2006. Under the terms of such documents, the shares earned will be issued on November 2, 2009.
- [F2]Deemed price per share as calculated under the terms of the operative documents pursuant to which Pharmos Corporation acquired Vela Pharmaceuticals Inc. in October 2006.
- [F3]Of the shares beneficially owned by Mr. Johnston, the following shares are held indirectly: 6,000,000 shares by Demeter Trust; 18,804 shares by Lynn Johnston; and 5,641 shares by each of 11/6/78 Trust FBO Bradford Dixon Johnston, 7/15/99 Trust FBO William McCord Johnston and 11/6/78 Trust FBO Alexandra Fowler Johnston.
- [F4]Shares of restricted stock granted pursuant to the Pharmos Corporation 2000 Stock Option Plan. The shares shall vest and become non-forfeitable as follows: 25% on the first anniversary of the grant date, and the remaining 75% in twelve equal quarterly increments over the next three years following the first anniversary of the grant date.
Documents
Issuer
PHARMOS CORP
CIK 0000713275
Entity typeother
Related Parties
1- filerCIK 0001422645
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 4:52 PM ET
- Size
- 8.3 KB